C. Arnold

发表

Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro‐entero‐pancreatic system

R. Arnold, H. Blum, A. Schmitt-Gräff, 2007 .

Loss of Nuclear p 27 Expression and Its Prognostic Role in Relation to Cyclin E and p 53 Mutation in Gastroenteropancreatic NeuroendocrineTumors

H. Stein, M. Zeitz, R. Arnold, 2008 .

Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

C. Compton, M. Bertagnolli, L. Wasserman, 2004, Cancer research.

Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors

H. Stein, M. Zeitz, J. Schrader, 2008, Clinical Cancer Research.

BASIC–ALIMENTARY TRACT The CpG Island Methylator Phenotype and Chromosomal Instability Are Inversely Correlated in Sporadic Colorectal Cancer

C. Compton, C. Boland, R. Goldberg, 2007 .

Placebo-Controlled , Double-Blind , Prospective , Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors : A Report From the PROMID Study Group

C. Schade-Brittinger, K. Klose, T. Gress, 2009 .

Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines

A. Goel, C. Boland, C. Arnold, 2003, International journal of cancer.

Characterization of sporadic colon cancer by patterns of genomic instability.

C. Compton, D. Chang, M. Bertagnolli, 2003, Cancer research.

Biology and Genetics of Colorectal Cancer and Polyps and Polyposis

A. Goel, C. Arnold, A. Goel, 2012 .

Molecular pathogenesis of colorectal cancer

H. Blum, A. Goel, C. Richard Boland, 2005, Cancer.

Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers

C. Compton, C. Boland, M. Bertagnolli, 2004, International journal of cancer.

Evaluation of Microsatellite Instability, hMLH1 Expression and hMLH1 Promoter Hypermethylation in Defining the MSI Phenotype of Colorectal Cancer

C. Compton, M. Bertagnolli, L. Wasserman, 2004, Cancer biology & therapy.

Multistep progression of colorectal cancer in the setting of microsatellite instability: new details and novel insights.

C. Boland, A. Goel, C. Arnold, 2001, Gastroenterology.

Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer.

C. Boland, R. Kolodner, J. Carethers, 2001, The Journal of pediatrics.

The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

C. Compton, M. Bertagnolli, R. Goldberg, 2007, Gastroenterology.

Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.

H. Stein, M. Zeitz, H. Scherübl, 2004, Neuroendocrinology.

APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q1

C. Compton, M. Bertagnolli, L. Wasserman, 2004, Cancer biology & therapy.

Tuberculous colitis mimicking Crohn's disease

H. Blum, D. Moradpour, C. Arnold, 1998, American Journal of Gastroenterology.

Trypsinogen Gene Mutations in Patients with Chronic or Recurrent Acute Pancreatitis

B. Seifert, H. Blum, F. von Weizsäcker, 2001, Pancreas.

Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.

R. Arnold, H. Blum, A. Schmitt-Gräff, 2006, International journal of cancer.

Identification of frame-shift intermediate mutant cells

C. Boland, L. Natarajan, C. Gasche, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Immunohistochemical Study of Mitosis-regulatory Proteins in Gastroenteropancreatic Neuroendocrine Neoplasms

M. Hummel, D. Hörsch, R. Arsenić, 2018, AntiCancer Research.

Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial.

W. Hiddemann, C. Schade-Brittinger, K. Klose, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors

R. Arnold, H. Blum, T. Nagasaka, 2008, International journal of cancer.

Nuclear Survivin Is a Powerful Novel Prognostic Marker in Gastroenteropancreatic Neuroendocrine Tumor Disease

H. Stein, M. Zeitz, H. Scherübl, 2005, Neuroendocrinology.

When to Look for Von Hippel-Lindau Disease in Gastroenteropancreatic Neuroendocrine Tumors?

H. Neumann, O. Schaefer, Hao Ling, 2004, Neuroendocrinology.

[Quality report 2011 of the German Society of Interventional Radiology (DeGIR)--part 2. Endovascular treatment of aortic aneurysms (EVAR)].

D. Morhard, L. Heuser, A. Bücker, 2013, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.

H. Blum, C. Arnold, A. Sosnowski, 2015, Annals of the New York Academy of Sciences.

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

C. Schade-Brittinger, K. Klose, T. Gress, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Qualitätsreport 2011: Bericht über die Behandlungsqualität minimalinvasiver Methoden – Teil 2 Interventionelle Therapie (EVAR) von Aortenaneurysmen

A. Bücker, D. Morhard, W. Gross-fengels, 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.